SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-240251
Filing Date
2011-09-02
Accepted
2011-09-02 17:05:47
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 914829
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 8635
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 8673
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4837
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4830
  Complete submission text file 0001193125-11-240251.txt   3433602

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hznp-20110630.xml EX-101.INS 510213
7 XBRL TAXONOMY EXTENSION SCHEMA hznp-20110630.xsd EX-101.SCH 13049
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20110630_cal.xml EX-101.CAL 39357
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20110630_def.xml EX-101.DEF 37907
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20110630_lab.xml EX-101.LAB 144009
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20110630_pre.xml EX-101.PRE 94122
Mailing Address 1033 SKOKIE BLVD SUITE 355 NORTHBROOK IL 60062
Business Address 1033 SKOKIE BLVD SUITE 355 NORTHBROOK IL 60062 224-383-3000
HORIZON PHARMA, INC. (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 111074158
SIC: 2834 Pharmaceutical Preparations